本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Inhibrx Biosciences

57.29
+28.93102.01%
盤後56.10-1.1900-2.08%19:59 EDT
成交量:607.94萬
成交額:3.17億
市值:8.30億
市盈率:-5.41
高:60.20
開:49.13
低:46.01
收:28.36
52周最高:60.20
52周最低:10.81
股本:1,448.54萬
流通股本:780.85萬
量比:13.18
換手率:77.86%
股息:- -
股息率:- -
每股收益(TTM):-10.5804
每股收益(LYR):114.01
淨資產收益率:-113.71%
總資產收益率:-26.29%
市淨率:12.10
市盈率(LYR):0.50

資料載入中...

2024/06/11

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/06/07

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/06/03

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2024/06/03

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2024/06/03

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/05/31

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/05/30

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/05/30

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/05/30

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/05/30

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/05/30

重要事件披露

Form 8-K - Current report
2024/05/30

交易所摘牌聲明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2024/05/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/24

重要事件披露

Form 8-K - Current report
2024/05/23

SEC問詢函

Form CORRESP - Correspondence
2024/05/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/17

重要事件披露

Form 8-K - Current report
2024/05/10

重要事件披露

Form 8-K - Current report
2024/05/10

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/08

重要事件披露

Form 8-K - Current report